Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial

BACKGROUND: Currently, endovascular treatment is indicated to treat femoropopliteal lesions ≤15 cm. However, the Achilles’ heel of femoropopliteal endovascular repair remains restenosis. Paclitaxel eluting stents have shown promising results to prevent restenosis in femoropopliteal lesions compared...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouëffic, Yann, Kaladji, Adrien, Guyomarch, Béatrice, Montagne, Carine, Fairier, Damien, Gestin, Simon, Riche, Valéry-Pierre, Vent, Pierre Alexandre, Chaillou, Philippe, Costargent, Alain, Patra, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226912/
https://www.ncbi.nlm.nih.gov/pubmed/25359394
http://dx.doi.org/10.1186/1745-6215-15-423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226912/
https://www.ncbi.nlm.nih.gov/pubmed/25359394
http://dx.doi.org/10.1186/1745-6215-15-423

Ejemplares similares